Cardiovascular Abnormalities Clinical Trial
Official title:
Electracupuncture Could Ameliorate Orthostatic Intolerance After Weightlessness by Improving Cardiovascular Function
To investigate the changes of cardiovascular function during short-term simulated weightlessness after electroacupuncture (EA) treatment.
Spaceflight is associated with cardiovascular deregulation. However, the influence of microgravity on the cardiovascular system and the underlying mechanisms and countermeasures remain largely unknown. Our previous studies have demonstrated that electroacupuncture (EA) is effective at improving orthostatic tolerance (OT). The purpose of this study was to determine if EA treatment can attenuate cardiovascular deconditioning induced by a 4-day −6° head-down bed rest (HDBR). Fourteen healthy male subjects were randomly allocated into a control group (Con, n=6, 4 days HDBR without countermeasure) and an EA treatment group (EA, n=8, 4 days HDBR with EA at Neiguan [PC-6] for 30 min daily for 4 consecutive days during HDBR). OT was estimated with a combination of +75°/20 min head-up tilt and lower body negative pressure test before and after HDBR. Plasma hormones and heart rate variability were assessed before and after HDBR. Cardiac systolic functions and cerebral blood flow were measured before, during, and after HDBR. The data showed that EA treatment applied daily for 30 min during a 4-day HDBR prevented OT and cardiac systolic function from decrease, prevented autonomic dysfunction (a decrease in the activity of the parasympathetic nervous system), and increased the concentrations of plasma angiotensin II (Ang II) and aldosterone (Ald). These results indicate that 30 min of daily EA treatment at PC-6 is highly effective in partially maintaining OT and cardiac systolic function. Activation of the peripheral sympathetic nervous system and increased plasma hormones is largely responsible for maintaining OT after a 4-day HDBR. Therefore, EA treatment appears to be an effective countermeasure against cardiovascular deconditioning induced by HDBR. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT05542238 -
The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury
|
N/A | |
Active, not recruiting |
NCT02973126 -
Heartflow (AFFECTS)
|
Phase 3 | |
Withdrawn |
NCT00844935 -
Electrocardiographic Autonomic Function Measures in Mechanically Ventilated Patients
|
N/A | |
Completed |
NCT01410487 -
Effects of Weight Loss on Cardio-respiratory Function
|
N/A | |
Withdrawn |
NCT00807274 -
Renal Function in Adults With Congenital Heart Disease.
|
N/A | |
Withdrawn |
NCT00468702 -
Postoperative Canadian Oral Anticoagulation Self-management (Post-COAGS) Trial
|
N/A | |
Completed |
NCT04340388 -
Contribution of Dolutegravir to Obesity and Cardiovascular Disease
|
Phase 4 | |
Completed |
NCT03545672 -
Early Identification of Myocardial Impairment in PBC
|
||
Completed |
NCT03758092 -
Cardiovascular Screening in Infants Born Small for Gestational Age
|
||
Recruiting |
NCT06091384 -
Inspiratory Muscle Strength Training in Post-Covid Syndrome
|
N/A | |
Completed |
NCT04586894 -
Adverse Myocardial and Vascular Side Effects of Immune Checkpoint Inhibitors
|
||
Completed |
NCT03826914 -
The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults
|
N/A | |
Not yet recruiting |
NCT05624255 -
Correlating the Measure of Retinal Vascular Density Through Angio-OCT With Calcium Score
|
N/A | |
Completed |
NCT02966028 -
Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)
|
Phase 2 | |
Completed |
NCT01820702 -
Short Term Bed Rest Study: Evaluation of the Use of Artificial Gravity, Induced by Short-arm Centrifugation
|
N/A | |
Recruiting |
NCT04766203 -
Relative Energy Deficiency in Sport Multicenter Study
|
N/A | |
Completed |
NCT01811667 -
Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
|
Phase 3 | |
Terminated |
NCT02351726 -
Mitroflow DL Post Approval Study- North America
|
N/A | |
Completed |
NCT02616913 -
Evaluation of the Cardiac Effects of a Novel Food Ingredient in Healthy Male Subjects
|
N/A | |
Completed |
NCT00901394 -
Vitamin B12 and Folate Administration on Homocysteine Concentrations After Nitrous Oxide Anesthesia
|
N/A |